Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2026-07-23 @ 9:00 PM
Study NCT ID:
NCT05295628
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-06
First Post:
2022-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
Sponsor:
Emblok, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLP 001-2021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |